Seeking Alpha

Biogen Idec (BIIB +4%) moves higher after BofA/ Merrill Lynch upgrades the shares to Buy from...

Biogen Idec (BIIB +4%) moves higher after BofA/ Merrill Lynch upgrades the shares to Buy from Neutral. Price target raised to $246 from $187.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)